全文获取类型
收费全文 | 1918篇 |
免费 | 164篇 |
国内免费 | 13篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 31篇 |
妇产科学 | 21篇 |
基础医学 | 334篇 |
口腔科学 | 52篇 |
临床医学 | 194篇 |
内科学 | 347篇 |
皮肤病学 | 94篇 |
神经病学 | 315篇 |
特种医学 | 80篇 |
外科学 | 216篇 |
综合类 | 2篇 |
一般理论 | 2篇 |
预防医学 | 125篇 |
眼科学 | 37篇 |
药学 | 88篇 |
中国医学 | 2篇 |
肿瘤学 | 140篇 |
出版年
2023年 | 53篇 |
2022年 | 73篇 |
2021年 | 125篇 |
2020年 | 77篇 |
2019年 | 95篇 |
2018年 | 103篇 |
2017年 | 74篇 |
2016年 | 91篇 |
2015年 | 106篇 |
2014年 | 103篇 |
2013年 | 124篇 |
2012年 | 172篇 |
2011年 | 147篇 |
2010年 | 83篇 |
2009年 | 76篇 |
2008年 | 86篇 |
2007年 | 84篇 |
2006年 | 92篇 |
2005年 | 79篇 |
2004年 | 77篇 |
2003年 | 39篇 |
2002年 | 55篇 |
2001年 | 12篇 |
2000年 | 6篇 |
1999年 | 6篇 |
1998年 | 7篇 |
1997年 | 2篇 |
1996年 | 4篇 |
1995年 | 6篇 |
1992年 | 3篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 3篇 |
1983年 | 1篇 |
1981年 | 1篇 |
1980年 | 3篇 |
1979年 | 1篇 |
1976年 | 1篇 |
1969年 | 1篇 |
1959年 | 2篇 |
1949年 | 1篇 |
1939年 | 1篇 |
1938年 | 1篇 |
1934年 | 2篇 |
1933年 | 1篇 |
1930年 | 2篇 |
1929年 | 2篇 |
1925年 | 1篇 |
1923年 | 1篇 |
排序方式: 共有2095条查询结果,搜索用时 218 毫秒
71.
Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay 总被引:1,自引:0,他引:1
下载免费PDF全文
![点击此处可从《Journal of clinical microbiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Musher DM Manhas A Jain P Nuila F Waqar A Logan N Marino B Graviss EA 《Journal of clinical microbiology》2007,45(8):2737-2739
Several kinds of laboratory techniques are available to detect Clostridium difficile toxin in fecal samples. Because questions have been raised about the reliability of immunoassays compared to the accepted standard, cytotoxicity assay, we studied three enzyme immunoassays (EIAs) and one rapid EIA, which demonstrated relatively good sensitivities and specificities compared to cytotoxicity assay. 相似文献
72.
Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children 总被引:1,自引:0,他引:1
Junge S Kloeckener-Gruissem B Zufferey R Keisker A Salgo B Fauchere JC Scherer F Shalaby T Grotzer M Siler U Seger R Güngör T 《European journal of immunology》2007,37(11):3270-3280
CD31(+)CD45RA(+)RO(-) lymphocytes contain high numbers of T cell receptor circle (TREC)-bearing T cells; however, the correlation between CD31(+)CD4(+) lymphocytes and TREC during aging and under lymphopenic conditions has not yet been sufficiently investigated. We analyzed TREC, telomere length and telomerase activity within sorted CD31(+) and CD31(-) CD4(+) lymphocytes in healthy individuals from birth to old age. Sorted CD31(+)CD45RA(+)RO(-) naive CD4(+) lymphocytes contained high TREC numbers, whereas CD31(+)CD45RA(-)RO(+) cells (comprising < or =5% of CD4(+) cells during aging) did not contain TREC. CD31(+) overall CD4(+) cells remained TREC rich despite an age-related tenfold reduction from neonatal (100 : 1000) to old age (10 : 1000). Besides a high TREC content, CD31(+)CD45RA(+)RO(-)CD4(+) cells exhibited significantly longer telomeres and higher telomerase activity than CD31(-)CD45RA(+)RO(-)CD4(+) cells, suggesting that CD31(+)CD45RA(+)RO(-)CD4(+) cells represent a distinct population of naive T cells with particularly low replicative history. To analyze the value of CD31 in lymphopenic conditions, we investigated six children after allogeneic hematopoietic stem cell transplantation (HSCT). Reemerging overall CD4(+) as well as naive CD45RA(+)RO(-)CD4(+) cells predominantly expressed CD31 and correlated well with the recurrence of TREC 5-12 months after HSCT. Irrespective of limitations in the elderly, CD31 is an appropriate marker to monitor TREC-rich lymphocytes essentially in lymphopenic children after HSCT. 相似文献
73.
Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines
下载免费PDF全文
![点击此处可从《Journal of applied toxicology : JAT》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Cécile Mingard Franziska Paech Jamal Bouitbir Stephan Krähenbühl 《Journal of applied toxicology : JAT》2018,38(3):418-431
Tyrosine kinase inhibitors have revolutionized the treatment of certain cancers. They are usually well tolerated, but can cause adverse reactions including liver injury. Currently, mechanisms of hepatotoxicity associated with tyrosine kinase inhibitors are only partially clarified. We therefore aimed at investigating the toxicity of regorafenib, sorafenib, ponatinib, crizotinib, dasatinib and pazopanib on HepG2 and partially on HepaRG cells. Regorafenib and sorafenib strongly inhibited oxidative metabolism (measured by the Seahorse‐XF24 analyzer) and glycolysis, decreased the mitochondrial membrane potential and induced apoptosis and/or necrosis of HepG2 cells at concentrations similar to steady‐state plasma concentrations in humans. In HepaRG cells, pretreatment with rifampicin decreased membrane toxicity (measured as adenylate kinase release) and dissipation of adenosine triphosphate stores, indicating that toxicity was associated mainly with the parent drugs. Ponatinib strongly impaired oxidative metabolism but only weakly glycolysis, and induced apoptosis of HepG2 cells at concentrations higher than steady‐state plasma concentrations in humans. Crizotinib and dasatinib did not significantly affect mitochondrial functions and inhibited glycolysis only weakly, but induced apoptosis of HepG2 cells. Pazopanib was associated with a weak increase in mitochondrial reactive oxygen species accumulation and inhibition of glycolysis without being cytotoxic. In conclusion, regorafenib and sorafenib are strong mitochondrial toxicants and inhibitors of glycolysis at clinically relevant concentrations. Ponatinib affects mitochondria and glycolysis at higher concentrations than reached in plasma (but possibly in liver), whereas crizotinib, dasatinib and pazopanib showed no relevant toxicity. Mitochondrial toxicity and inhibition of glycolysis most likely explain hepatotoxicity associated with regorafenib, sorafenib and possibly pazopanib, but not for the other compounds investigated. 相似文献
74.
Beesdo-Baum Katja Knappe Susanne Einsle Franziska Knothe Lisa Wieder Gesine Venz John Rummel-Kluge Christine Heinz Ines Koburger Nicole Schouler-Ocak Meryam Wilbertz Theresia Unger Hans-Peter Walter Ulrich Hein Joachim Hegerl Ulrich Lieb Roselind Pfennig Andrea Schmitt Jochen Hoyer Jürgen Wittchen Hans-Ulrich Bergmann Antje 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2018,61(1):52-64
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Hausärzte sind als Primärversorger für Patienten mit depressiven Störungen entscheidende Weichensteller... 相似文献
75.
Lev Gorfinkel Franziska Wachter Hong-yuan Luo Eileen Hansbury David A. Williams Archana Agarwal David H. K. Chui Alan B. Cantor 《Pediatric blood & cancer》2023,70(1):e30067
Unstable gamma globin variants can cause transient neonatal hemolytic anemia. We have identified a novel variant in a newborn who presented with jaundice and anemia requiring phototherapy and red blood cell transfusion. The patient was found to be heterozygous for the mutation HGB2:c.290T>C, p.Leu97Pro, which we have termed hemoglobin (Hb) Wareham. This substitution is expected to generate an unstable hemoglobin with increased oxygen affinity based on the homologous mutation previously described in the beta globin gene, which is termed as Hb Debrousse. The patient fully recovered by 9 months of age as expected with the transition from fetal to adult hemoglobin. 相似文献
76.
77.
Sarah Bonk MD Martina Kluth PhD Kristina Jansen MD Claudia Hube-Magg PhD Georgia Makrypidi-Fraune PhD Doris Höflmayer MD Sören Weidemann MD Katharina Möller MD Ria Uhlig MD Franziska Büscheck MD Andreas M. Luebke MD Eike Burandt MD Till S. Clauditz MD Stefan Steurer MD Thorsten Schlomm MD Hartwig Huland MD Hans Heinzer MD Guido Sauter MD Ronald Simon PhD David Dum MD 《The Prostate》2020,80(13):1097-1107
78.
Baum Sven Holger Oeverhaus Michael Saxe Franziska Mohr Christopher 《Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie》2020,258(10):2305-2312
Graefe's Archive for Clinical and Experimental Ophthalmology - This study aims to analyse the various modifications of orbital exenteration. Patients undergoing orbital exenteration from March... 相似文献
79.
Matthias Vonmoos Lea M Hulka Katrin H Preller Franziska Minder Markus R Baumgartner Boris B Quednow 《Neuropsychopharmacology》2014,39(9):2200-2210
Cocaine users consistently display cognitive impairments. However, it is still unknown whether these impairments are cocaine-induced and if they are reversible. Therefore, we examined the relation between changing intensity of cocaine use and the development of cognitive functioning within 1 year. The present data were collected as part of the longitudinal Zurich Cocaine Cognition Study (ZuCo2St). Forty-eight psychostimulant-naive controls and 57 cocaine users (19 with increased, 19 with decreased, and 19 with unchanged cocaine use) were eligible for analysis. At baseline and after a 1-year follow-up, cognitive performance was measured by a global cognitive index and four neuropsychological domains (attention, working memory, declarative memory, and executive functions), calculated from 13 parameters of a broad neuropsychological test battery. Intensity of cocaine use was objectively determined by quantitative 6-month hair toxicology at both test sessions. Substantially increased cocaine use within 1 year (mean +297%) was associated with reduced cognitive performance primarily in working memory. By contrast, decreased cocaine use (−72%) was linked to small cognitive improvements in all four domains. Importantly, users who ceased taking cocaine seemed to recover completely, attaining a cognitive performance level similar to that of the control group. However, recovery of working memory was correlated with age of onset of cocaine use—early-onset users showed hampered recovery. These longitudinal data suggest that cognitive impairment might be partially cocaine-induced but also reversible within 1 year, at least after moderate exposure. The reversibility indicates that neuroplastic adaptations underlie cognitive changes in cocaine users, which are potentially modifiable in psychotherapeutical or pharmacological interventions. 相似文献
80.
Haasen C Prinzleve M Zurhold H Rehm J Güttinger F Fischer G Jagsch R Olsson B Ekendahl M Verster A Camposeragna A Pezous AM Gossop M Manning V Cox G Ryder N Gerevich J Bacskai E Casas M Matali JL Krausz M 《European addiction research》2004,10(4):139-146
An increase in the use of cocaine and crack in several parts of Europe has raised the question whether this trend is similar to that of the USA in the 1980s. However, research in the field of cocaine use in Europe has been only sporadic. Therefore, a European multi-centre and multi-modal project was designed to study specific aspects of cocaine and crack use in Europe, in order to develop guidelines for public health strategies. Data on prevalence rates were analysed for the general population and for specific subgroups. Despite large differences between countries in the prevalence of cocaine use in the general population, most countries show an increase in the last few years. The highest rate with a lifetime prevalence of 5.2% was found for the United Kingdom, although with a plateau effect around the year 2000. With regard to specific subgroups, three groups seem to show a higher prevalence than the general population: (1) youth, especially in the party scene; (2) socially marginalized groups, such as homeless and prostitutes or those found in open drug scenes; (3) opiate-dependent patients in maintenance treatment who additionally use cocaine. Specific strategies need to be developed to address problematic cocaine use in these subgroups. 相似文献